C12N 2760/18134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2760/18134 (Use of virus or viral component as vaccine) appears on 160 US grants and 184 published applications in this corpus.
Search patents in C12N- Granted patents
- 160
- Published applications
- 184
- Assignees
- 104
- Inventors
- 385
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 0 |
| 2002 | 5 | 2 |
| 2003 | 3 | 3 |
| 2004 | 3 | 3 |
| 2005 | 1 | 4 |
| 2006 | 2 | 1 |
| 2007 | 3 | 5 |
| 2008 | 2 | 2 |
| 2009 | 4 | 9 |
| 2010 | 2 | 15 |
| 2011 | 5 | 7 |
| 2012 | 2 | 8 |
| 2013 | 1 | 5 |
| 2014 | 4 | 14 |
| 2015 | 7 | 6 |
| 2016 | 13 | 10 |
| 2017 | 8 | 11 |
| 2018 | 7 | 12 |
| 2019 | 17 | 8 |
| 2020 | 5 | 8 |
| 2021 | 5 | 13 |
| 2022 | 9 | 13 |
| 2023 | 3 | 7 |
| 2024 | 6 | 8 |
| 2025 | 8 | 8 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of beta-glucan extract in the immunopotentiation of an avian animal28 Apr 2026US 12,611,420 B2Lesaffre Et Compagnie
- Multivalent HVT vector vaccine31 Mar 2026US 12,589,147 B2Intervet Inc.
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Gallid alphaherpesvirus 3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry18 Nov 2025US 12,473,572 B1FarmacolóGicos Veterinarios S.A.C.
- tFIBER protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use14 Oct 2025US 12,440,551 B2Pulike Biological Engineering, Inc.
- Virus attenuation30 Apr 2026US 2026/0115273 A1University of Lancaster
- Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same5 Mar 2026US 2026/0061047 A1Biopoa, Inc.
- New multivalent hvt vector vaccine20 Nov 2025US 2025/0352642 A1Intervet Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Vaccine against infectious bronchitis25 Sep 2025US 2025/0295752 A1Zoetis Services LLC
Most cited
By later US patents
- Recombinant new castle disease virus RNA expression systems and vaccines164US 6,146,642 AMount Sinai School of Medicine of the City University of New York · 2000
- Process for the production of virus vaccine116US 4,659,569 AKabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo · 1987
- Chicken interleukin-15 and uses thereof88US 6,737,522 B2Wayne State University · 2004
- Newcastle disease virus combination vaccine59US 5,733,556 AAkzo Nobel N. V. · 1998
- Methods and interferon deficient substrates for the propagation of viruses37US 6,852,522 B1Mount Sinai School of Medicine of New York University · 2005